ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,132 | -31.9% | 6,044 | -15.1% | 0.00% | – |
| Q2 2023 | $26,610 | -40.6% | 7,115 | -46.8% | 0.00% | – |
| Q1 2023 | $44,793 | -68.2% | 13,371 | -54.3% | 0.00% | – |
| Q4 2022 | $140,697 | -15.8% | 29,251 | 0.0% | 0.00% | – |
| Q3 2022 | $167,000 | -17.7% | 29,251 | +2.6% | 0.00% | – |
| Q2 2022 | $203,000 | +125.6% | 28,507 | +130.0% | 0.00% | – |
| Q1 2022 | $90,000 | -18.9% | 12,397 | 0.0% | 0.00% | – |
| Q4 2021 | $111,000 | -74.5% | 12,397 | 0.0% | 0.00% | – |
| Q3 2021 | $435,000 | +150.0% | 12,397 | +53.4% | 0.00% | – |
| Q2 2021 | $174,000 | +87.1% | 8,080 | +435.5% | 0.00% | – |
| Q1 2021 | $93,000 | -93.3% | 1,509 | -95.5% | 0.00% | -100.0% |
| Q4 2020 | $1,394,000 | – | 33,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |